Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) is highly prevalent among adolescents enrolled in behavioral health services but remains undertreated in this age group. Also the first-line treatment for adolescent ADHD, stimulant medication, is underutilized in routine practice. This article briefly describes three behavioral interventions designed to promote stronger integration of medication interventions into treatment planning for adolescent ADHD: family ADHD psychoeducation, family-based medication decision-making, and behavior therapist leadership in coordinating medication integration. It then introduces the Medication Integration Protocol (MIP), which incorporates all three interventions into a five-task protocol: ADHD Assessment and Medication Consult; ADHD Psychoeducation and Client Acceptance; ADHD Symptoms and Family Relations; ADHD Medication and Family Decision-Making; and Medication Management and Integration Planning. The article concludes by highlighting what behavior therapists should know about best practices for medication integration across diverse settings and populations: integrating medication interventions into primary care, managing medication priorities and polypharmacy issues for adolescents with multiple diagnoses, providing ADHD medications to adolescent substance users, and the compatibility of MIP intervention strategies with everyday practice conditions.
Child Fam Behav Ther. 2014 Oct 1. doi: 10.1080/07317107.2014.967631.
Aaron Hogue, Ph.D.
Senior Vice President, Research and Clinical Science / Family and Adolescent Clinical Technology and Science (FACTS)
Molly Bobek, L.C.S.W.
Vice President, Family and Adolescent Clinical Technology and Science (FACTS)
Gregory T. Zau, M.D., Ph.D.
Frances R. Levin, M.D.
Last Updated
November 2023